Biomarker-based Prognostication
Biomarker-Based Prognostication is a clinical assessment approach that uses quantifiable biological markers to predict the future course of neurological outcomes, distinguished by its reliance on objective, measurable molecular, imaging, or electrophysiological indicators to inform disease progression, recovery potential, or risk of deterioration in neurologic disorders.
361
Publications
19.6K
Citations
3.4K
Authors
1.1K
Institutions
Publications per year
2017–2026
192
Parents
361
Paul W. Sperduto, Shane Mesko, Jing Li et al. · Journal of Clinical Oncology · 2020 · 467 citations · Full text
John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills et al. · Blood · 2012 · 419 citations
1–5 of 361
3.4K
8
h-index
7
h-index
5
h-index
5
h-index
5
h-index
1–5 of 3.4K
1.1K
Harvard University
Cambridge, United States
14 h-index
56 publications
2.8K citations
University College London
London, United Kingdom
13 h-index
41 publications
1.9K citations
Massachusetts General Hospital
Boston, United States
13 h-index
47 publications
3.8K citations
Inserm
Paris, France
12 h-index
83 publications
3.1K citations

University of Gothenburg
Gothenburg, Sweden
11 h-index
30 publications
1.4K citations
Heidelberg University
Heidelberg, Germany
11 h-index
29 publications
3.4K citations

Sahlgrenska University Hospital
Gothenburg, Sweden
10 h-index
23 publications
1.2K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
10 h-index
39 publications
1.8K citations
1–8 of 1.1K
12 publications · 626 citations
11
h-index
Repository · 8 publications · 192 citations
8
h-index
6 publications · 145 citations
6
h-index
6 publications · 177 citations
6
h-index
6 publications · 257 citations
6
h-index
1–5